HealthWatchlist verdict: Rosemary has a limited human research signal for pattern hair loss. The evidence does not establish that ordinary rosemary oil is equivalent to minoxidil, and newer blend studies do not settle that question.
The precise claim
This review asks whether topical rosemary oil increases hair growth in people with androgenetic alopecia, also called pattern hair loss. It does not assume that all shedding has the same cause.
A bottle of essential oil, a leaf extract, a rosemary water rinse and a formulated scalp product can differ substantially. Evidence for one preparation should not become a promise for everything bearing the plant’s name.
The trial behind the minoxidil comparison
The widely cited 2015 trial assigned 100 people with androgenetic alopecia to rosemary oil or 2% minoxidil for six months. Hair counts did not significantly increase at three months. Both groups improved by six months, without a statistically significant difference between groups.
That result warrants interest, but “no significant difference” does not establish equivalence. A study designed to demonstrate equivalence needs suitable statistical methods and a predefined margin. An active-comparator trial also does not show how much either group would have changed with an inactive treatment.
The comparison was with 2% minoxidil. It cannot establish equivalence to 5% minoxidil, oral treatment, or every treatment used for pattern hair loss. Claims that rosemary has been proved just as effective as any minoxidil product go beyond the experiment.
What newer studies add
A 2025 trial of 90 participants compared rosemary-lavender and rosemary-castor formulations with coconut oil over 90 days. The authors reported improvements in several hair measurements. These were mixed formulations in a population described as healthy participants, rather than a straightforward replication of rosemary alone for diagnosed pattern hair loss.
Without separate rosemary-only and other-ingredient-only groups, the contribution of each ingredient remains uncertain. Multiple outcomes and short follow-up also make long-term claims premature. A photographed increase in hair length is not interchangeable with preventing progressive follicle loss.
A 2025 review of controlled herbal hair-loss trials likewise describes promising findings alongside inconsistent designs and outcomes. Its discussion includes many different plants. The overall number of herbal trials is not the number of independent rosemary trials.
A newer rosemary and castor-oil experiment used mice. It may inform further research, but does not supply the missing human replication. Reports about scalp circulation, inflammation or hormone pathways should be read at the level actually tested.
Why alopecia areata is a separate question
An older trial tested thyme, rosemary, lavender and cedarwood together in alopecia areata. It provides evidence about a mixture and a different diagnosis. It cannot identify rosemary as the active ingredient or resolve the pattern-hair-loss question.
The British Association of Dermatologists describes alopecia areata as an autoimmune condition. Patchy loss therefore deserves assessment rather than being folded into a generic promise about “hair growth”.
How to judge a product claim
| Claim on a label or advert | What to check |
|---|---|
| “Clinically proven rosemary” | Was that exact finished product tested, or only a different rosemary preparation? |
| “As effective as minoxidil” | Which concentration, population, duration and comparison supported the statement? |
| “Works within weeks” | The main rosemary-versus-minoxidil trial found no significant hair-count increase at three months. |
| “A natural treatment for every kind of hair loss” | Pattern loss, alopecia areata, breakage and temporary shedding are different problems. |
Safety and a sensible next step
A clinical review documents contact allergy to essential oils. Increasing the concentration to chase faster results can make an already troublesome scalp more irritated. This review does not provide a homemade treatment recipe because the evidence cannot validate one.
NHS guidance recommends discussing worrying hair loss with a GP before paying for a commercial hair clinic. A diagnosis helps establish which treatments are appropriate. If you already use prescribed treatment, discuss any proposed change rather than assuming the rosemary trial makes it redundant.
Evidence score and conclusion
John’s Evidence Score: 4/10 for topical rosemary and hair growth in androgenetic alopecia. A direct comparative human trial lifts this above laboratory theory. Limited replication, preparation differences and uncertainty about the comparator prevent a stronger rating.
Rosemary remains a research candidate. The useful finding is that there is something to investigate, rather than a reliable basis for replacing established treatment.
How this review was researched
Research checked on 12 September 2026. We searched PubMed using the oil or preparation name and the condition, checked relevant reviews and their cited trials, and consulted the official guidance linked below. This is an editorial review, not an exhaustive systematic review. Laboratory findings, combination products and uncontrolled reports are distinguished from controlled evidence for the exact claim.
Related reading
References
- Rosemary oil vs minoxidil 2% for the treatment of androgenetic alopecia: a randomized comparative trial.
- Rosmagain™ as a Natural Therapeutic for Hair Regrowth and Scalp Health: A Double-Blind, Randomized, Three-Armed, Placebo-Controlled Clinical Trial.
- Pathophysiology, conventional treatments, and evidence-based herbal remedies of hair loss with a systematic review of controlled clinical trials.
- An Exploratory Preclinical In Vivo Pilot Study Evaluating the Hair Growth-Promoting Effects of Rosmarinus officinalis and Ricinus communis Combination.
- Randomized trial of aromatherapy. Successful treatment for alopecia areata.
- Essential Oils, Part IV: Contact Allergy.
- NHS: Hair loss
- British Association of Dermatologists: Alopecia areata